China Medical System Holdings Limited (HKG:0867)
13.65
+0.45 (3.41%)
Sep 5, 2025, 4:08 PM HKT
HKG:0867 Revenue
China Medical System Holdings had revenue of 4.00B CNY in the half year ending June 30, 2025, a decrease of -13.19%. This brings the company's revenue in the last twelve months to 7.86B, up 12.06% year-over-year. In the year 2024, China Medical System Holdings had annual revenue of 7.47B, down -6.79%.
Revenue (ttm)
7.86B CNY
Revenue Growth
+12.06%
P/S Ratio
3.83
Revenue / Employee
1.28M CNY
Employees
6,141
Market Cap
32.99B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 7.47B | -544.30M | -6.79% |
Dec 31, 2023 | 8.01B | -1.14B | -12.43% |
Dec 31, 2022 | 9.15B | 813.13M | 9.75% |
Dec 31, 2021 | 8.34B | 1.39B | 20.03% |
Dec 31, 2020 | 6.95B | 872.34M | 14.36% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeOne Medicines AG | 35.81B |
Hansoh Pharmaceutical Group Company | 14.45B |
JD Health International | 71.34B |
Innovent Biologics | 12.52B |
Sino Biopharmaceutical | 33.49B |
WuXi Biologics | 21.98B |
Akeso | 2.75B |
CSPC Pharmaceutical Group | 28.49B |
China Medical System Holdings News
- 5 weeks ago - Alpha Cognition Announces Partner China Medical System Has NDA Accepted in China for the Review of ZUNVEYL® (Benzgalantamine) for Alzheimer’s Disease - Financial Post
- 8 months ago - Alpha Cognition Inks $44 Million Licensing Pact For Its Alzheimer's Drug In China - Benzinga